{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Chestnut Ridge",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "86202",
      "recalling_firm": "Par Pharmaceutical Inc.",
      "address_1": "1 Ram Ridge Rd",
      "address_2": "N/A",
      "postal_code": "10977-6714",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to 9 major distributors throughout the United States.",
      "recall_number": "D-1542-2020",
      "product_description": "BusPIRone Hydrochloride Tablets, USP 7.5 mg  NDC# 49884-725-01",
      "product_quantity": "11,347 bottles",
      "reason_for_recall": "Failed Impurity /Degradation Specifications",
      "recall_initiation_date": "20200810",
      "center_classification_date": "20200825",
      "termination_date": "20210607",
      "report_date": "20200902",
      "code_info": "Lot # 32091002, exp. date May 2021"
    }
  ]
}